Marcin Imieliński, MD, PhD, is a Core Faculty Member at the New York Genome Center. He holds a joint appointment as Director of Cancer Genomics at NYU Langone Health’s Perlmutter Cancer Center.
Dr. Imieliński is a board-certified molecular genetic pathologist. His research includes more than 40 peer-reviewed publications across several areas of genomics and computational biology. His lab uses cutting-edge sequencing technology and genomic data science to study patterns of complex and noncoding somatic DNA variation in cancer. Dr. Imieliński’s research interests are to apply high-throughput sequencing and computation to study patterns of somatic genomic variation in cancer. He is specifically interested in probing long-range cancer genome structure through the use of cutting-edge sequencing protocols and the development of novel machine learning and data visualization approaches. Dr. Imieliński is committed to expanding the role of computation and data science in laboratory medicine, and envisions a future in which “quantitative pathologists” help direct treatment choices through the application of statistical intuition and sophisticated multivariate analyses.
He is a recipient of a Burroughs Wellcome Career Award for Medical Scientists, a Clinical Scientist Development Award from the Doris Duke Charitable Foundation, and The Black Family-MRA Team Science Award.
Dr. Imieliński received a BS in Computer Science from Rutgers College. He obtained a PhD in genomics and computational biology and his MD from the University of Pennsylvania School of Medicine. He completed his residency in pathology at the Massachusetts General Hospital, and a fellowship in molecular genetic pathology at Harvard Medical School.
Prior to joining the New York Genome Center, he was a postdoctoral fellow in computational cancer genomics at the Broad Institute of Harvard and MIT, under the mentorship of Drs. Matthew Meyerson and Gad Getz.